The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15608
StudyName: Eligibility HER2-positive Breast Cancer NCT00436254
Date of export from the portal: 02.07.2020
Date of Upload / last change: 04.06.2016
License: Creative Commons BY 4.0

----

Description: 
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00436254
